Vitiligine (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vitiligine" in Italian language version.

refsWebsite

Global rank Italian rank

36nih.gov

4^th place

9^th place

16google.it

215^th place

4^th place

8web.archive.org

1^st place

6doi.org

2^nd place

7^th place

4sidemast.org

low place

3oadoi.org

799^th place

22^nd place

2nejm.org

2,374^th place

1,283^rd place

2europa.eu

68^th place

57^th place

1dermnetnz.org

7,563^rd place

low place

1nature.com

234^th place

226^th place

1farmacianews.it

low place

1jidonline.org

low place

1hindawi.com

6,828^th place

7,615^th place

1nnjournal.net

low place

1globale-dermatologie.com

low place

1jwatch.org

low place

1drugbank.ca

4,294^th place

low place

1aad.org

low place

aad.org

Melasma Treatment Archiviato il 23 dicembre 2009 in Internet Archive., American Academy of Dermatology.

dermnetnz.org

DermNet New Zealand How is the severity of vitiligo assessed?

doi.org

dx.doi.org

Chelsea Casey e Stephen E. Weis, Insight into Natural History of Congenital Vitiligo: A Case Report of a 23-Year-Old with Stable Congenital Vitiligo, in Case Reports in Dermatological Medicine, vol. 2017, 2017, DOI:10.1155/2017/5172140. URL consultato il 2 febbraio 2021.
Ezzedine K, Eleftheriadou V, Whitton M,, 'Vitiligo, in Lancet, vol. 386, 2015, pp. 74-84, DOI:10.1016/S0140-6736(14)60763-7.
Ezzedine K, Lim HW, Suzuki T, e al., Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, in Pigment cell & melanoma research, vol. 25, n. 3, 2012, pp. 1-13, DOI:10.1111/j.1755-148X.2012.00997.x, PMC 3511780.
Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K., Interventions for vitiligo, in Cochrane Database of Systematic Reviews, vol. 2., 2015, DOI:10.1002/14651858.CD003263.
(EN) Jean L. Bolognia, Kim Lapia e Sandra Somma, Depigmentation therapy, in Dermatologic Therapy, vol. 14, n. 1, 1º gennaio 2001, pp. 29-34, DOI:10.1046/j.1529-8019.2001.014001029.x. URL consultato il 4 febbraio 2018.
Vidhya Hariharan, Jared Klarquist e Mary J. Reust, Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation, in The Journal of Investigative Dermatology, vol. 130, n. 1, gennaio 2010, pp. 211-220, DOI:10.1038/jid.2009.214. URL consultato il 4 febbraio 2018.

drugbank.ca

Hydroquinone, su drugbank.ca. URL consultato il 4 febbraio 2018.

europa.eu

eur-lex.europa.eu

Regolamento europeo sui prodotti cosmetici 30 novembre 2009, su eur-lex.europa.eu. URL consultato il 4 febbraio 2018.

ema.europa.eu

EMA: Assessment report Arctostaphylos uva-ursi (L.) Spreng., folium

farmacianews.it

La vitiligine spesso si accompagna ad altre condizioni autoimmuni, su farmacianews.it.

globale-dermatologie.com

(FR) Idrochinone (Italiano) « Globale Dermatologie, su globale-dermatologie.com. URL consultato il 4 febbraio 2018.

google.it

books.google.it

Picardo,Taïeb: Vitiligo, Occupational vitiligo, pp. 175-180. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Historical aspects, pp.3-8. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Kobner's phenomenom, pp. 167-174. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Mucosal vitiligo, pp. 41-50. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Generalized vitiligo, pp. 35-38. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Vitiligo universalis, pp. 51-56. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Segmental vitiligo, pp. 35-38. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Scoring, p.130. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Epidemiology, Deﬁnitions and Classiﬁcation, pp.13-24. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo, Dell'Anna: Vitiligine, Epidemiologia. Mauro Picardo, Maria Lucia Dell'Anna, Vitiligine, SICS Editore, 1º ottobre 2015, ISBN 978-88-6930-971-7.
Picardo,Taïeb: Vitiligo, R.Spritz, Genetic, pp. 155-161. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Vitiligo and Immunodeﬁciences, pp.91-98. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, M. Picardo, M. L. Dell’Anna, Oxidative stress, pp.231-238. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Y. Gauthier, L. Benzekri , The Neurogenic Hypothesis in Segmental Vitiligo ,pp.302-305. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, The Viral Hypotheses, pp.292-293. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.
Picardo,Taïeb: Vitiligo, Other Hypotheses, pp.291-293. Mauro Picardo, Alain Taïeb, Vitiligo, Springer Science & Business Media, 26 marzo 2010, ISBN 978-3-540-69361-1.

hindawi.com

Nooshin Bagherani, The Newest Hypothesis about Vitiligo: Most of the Suggested Pathogeneses of Vitiligo Can Be Attributed to Lack of One Factor, Zinc-α2-Glycoprotein, in ISRN Dermatology, 2012.

jidonline.org

Lerner AB., Vitiligo., in J Invest Dermatol., vol. 32, 1959, pp. 285-310.

jwatch.org

Monobenzone as Immunotherapy for Melanoma, su jwatch.org.

nature.com

Ying Jin e al., Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants, in Nat Genet, vol. 48, n. 11, Nature Publishing Group, 2016, pp. 1418-1424.

nejm.org

nih.gov

ncbi.nlm.nih.gov

Chelsea Casey e Stephen E. Weis, Insight into Natural History of Congenital Vitiligo: A Case Report of a 23-Year-Old with Stable Congenital Vitiligo, in Case Reports in Dermatological Medicine, vol. 2017, 2017, DOI:10.1155/2017/5172140. URL consultato il 2 febbraio 2021.
A. Shai, D. Vardy; A. Zvulunov, Psoriasis, biblical afflictions and patients' dignity., in Harefuah, vol. 141, nº 5, maggio 2002, pp. 479-82, 496, PMID 12073533.
Ezzedine K, Lim HW, Suzuki T, e al., Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, in Pigment cell & melanoma research, vol. 25, n. 3, 2012, pp. 1-13, DOI:10.1111/j.1755-148X.2012.00997.x, PMC 3511780.
Zhang Y, Cai Y, Shi M, e al., The Prevalence of Vitiligo: A Meta-Analysis., in PLoS ONE, vol. 11, n. 9, 2016.
Nath SK, Majumder PP, Nordlund JJ (1994). "Genetic epidemiology of vitiligo: multilocus recessivity cross-validated". American Journal of Human Genetics 55 (5): 981–90. PMC 1918341. PMID 7977362.
SPRITZ RA., Modern vitiligo genetics sheds new light on an ancient disease., in The Journal of dermatology., vol. 40, n. 5, 2013.
Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, e al., Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP., in J Invest Dermatol., vol. 131, 2011, pp. 371-381.
Spritz RA., The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma., in Genome Med., vol. 2, n. 10, 2010, p. 78.
Lamkanfi M, Vande Walle L, Kanneganti TD (2011). "Deregulated inflammasome signaling in disease".
Ines D, Sonia B, Riadh BM, Amel el G, Slaheddine M, Hamida T, Hamadi A, Basma H., A comparative study of oxidant-antioxidant status in stable and active vitiligo patients., in Arch Dermatol Res., vol. 298, 2006, pp. 147-152.
Yildirim M, Baysal V, Inaloz HS, Can M., The role of oxidants and antioxidants in generalized vitiligo at tissue level., in J Eur Acad Dermatol Venereol., vol. 18, 2004, pp. 683-686.
Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B, Rao TR., Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin., in Indian J Dermatol Venereol Leprol., vol. 75, 2009, pp. 268-271.
Schallreuter KU, Wood JM, Ziegler I, Lemke KR, Pittelkow MR, Lindsey NJ, Gütlich M., Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo., in Biochim Biophys Acta., vol. 1226, 1994, pp. 181-192.
Hasse S, Gibbons NC, Rokos H, Marles LK, Schallreuter KU., Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress., in J Invest Dermatol., vol. 122, 2004, pp. 307-313.
Morrone A, Picardo M, de Luca C, Terminali O, Passi S, Ippolito F., Catecholamines and vitiligo., in Pigment Cell Res., vol. 5, 1992, pp. 65-69.
Schallreuter KU, Wood JM, Pittelkow MR, Buttner G, Swanson N, Korner C, Ehrke C., Increased monoamine oxidase A activity in the epidermis of patients with vitiligo., in Arch Dermatol Res., vol. 288, 1996, pp. 14-18.
Al’Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ., Neuropeptide and neuronal marker studies in vitiligo., in Br J Dermatol., vol. 131, 1994, pp. 160-165.
Wu CS, Yu HS, Chang HR, Yu CL, Yu CL, Wu BN., Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions., in J Dermatol Sci., vol. 23, 2000, pp. 53-62.
Bagherani N, Yaghoobi R, Omidian M., Hypothesis: zinc can be effective in treatment of vitiligo., in Indian J Dermatol., vol. 56, 2011, pp. 480-484.
Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, Barutcuoglu B, Erdem L., Is there any relationship between hepatitis C virus and vitiligo?, in J Clin Gastroenterol., vol. 38, 2004, pp. 815-817.
Akcan Y, Kavak A, Sertbas Y, Olut AI, Korkut E, Bicik Z, Kisacik B., The low seropositivity of hepatitis B virus in vitiligo patients., in J Eur Acad Dermatol Venereol., vol. 20, 2006, pp. 110-111.
Toker SC, Sarycaoglu H, Karadogan SK, Mistik R, Baskan EB, Tunaly S., Is there any relation between vitiligo and cytomegalovirus?, in J Eur Acad Dermatol Venereol., vol. 21, 2007, pp. 141-142.
Niamba P, Traoré A, Taïeb A., Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy, in Ann Dermatol Venereol., vol. 134, 2007, pp. 272-273.
Boissy RE, Liu YY, Medrano EE, Nordlund JJ., Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients., in J Invest Dermatol., vol. 97, 1991, pp. 395-404.
van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P., Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site., in Lab Invest., vol. 80, 2000, pp. 1299-1309.
Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taïeb A., Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo., in Br J Dermatol., vol. 148, 2003, pp. 95-101.
Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D., Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis., in Histol Histopathol., vol. 24, 2009, pp. 849-857.
Gauthier Y, Cario Andre M, Taïeb A., A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?, in Pigment Cell Res., vol. 16, 2003, pp. 322-332.
Bordignon M, et al., Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo., in J Dermatol Sci., vol. 71, 2013, pp. 142-145.
Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study
Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC, Autoimmune disease in families with multiple sclerosis: a population-based study
Dillon AB, Sideris A, Hadi A, Elbuluk N., Advances in Vitiligo: An Update on Medical and Surgical Treatments., in The Journal of Clinical and Aesthetic Dermatology., vol. 10, n. 1, 2017, pp. 15-28.
Vidhya Hariharan, Jared Klarquist e Mary J. Reust, Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation, in The Journal of Investigative Dermatology, vol. 130, n. 1, gennaio 2010, pp. 211-220, DOI:10.1038/jid.2009.214. URL consultato il 4 febbraio 2018.
Bo-Sik Kim, Young-Guk Na, Jae-Hwan Choi, Inhye Kim, Eunji Lee, Sung-Yeon Kim, Jae-Young Lee, e Cheong-Weon Cho1, The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers

niams.nih.gov

"Questions and Answers about Vitiligo.

ghr.nlm.nih.gov

Genetics Home Reference: Vitiligo

nnjournal.net

Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics

oadoi.org

Ezzedine K, Eleftheriadou V, Whitton M,, 'Vitiligo, in Lancet, vol. 386, 2015, pp. 74-84, DOI:10.1016/S0140-6736(14)60763-7.
Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K., Interventions for vitiligo, in Cochrane Database of Systematic Reviews, vol. 2., 2015, DOI:10.1002/14651858.CD003263.
(EN) Jean L. Bolognia, Kim Lapia e Sandra Somma, Depigmentation therapy, in Dermatologic Therapy, vol. 14, n. 1, 1º gennaio 2001, pp. 29-34, DOI:10.1046/j.1529-8019.2001.014001029.x. URL consultato il 4 febbraio 2018.

sidemast.org

linee guida Sidemast, p. 135. T. Lotti, P.G. Calzavara-Pinton, M. Picardo, L. Naldi, G. Buggiani, S. Berti, Linee Guida e raccomandazIonI SIDeMaST, Società Italiana di Dermatologia medica, chirurgica, estetica e delle Malattie Sessualmente Trasmesse : Vitiligine (PDF), Pacini Editore S.p.a., pp. 131-144.
linee guida Sidemast, p. 134. T. Lotti, P.G. Calzavara-Pinton, M. Picardo, L. Naldi, G. Buggiani, S. Berti, Linee Guida e raccomandazIonI SIDeMaST, Società Italiana di Dermatologia medica, chirurgica, estetica e delle Malattie Sessualmente Trasmesse : Vitiligine (PDF), Pacini Editore S.p.a., pp. 131-144.
linee guida Sidemast, pp. 137-138. T. Lotti, P.G. Calzavara-Pinton, M. Picardo, L. Naldi, G. Buggiani, S. Berti, Linee Guida e raccomandazIonI SIDeMaST, Società Italiana di Dermatologia medica, chirurgica, estetica e delle Malattie Sessualmente Trasmesse : Vitiligine (PDF), Pacini Editore S.p.a., pp. 131-144.
Guideline on Vitiligo Developed by the Guideline Subcommittee Vitiligo of the European Dermatology Forum (PDF), 2014.

web.archive.org

Associazione Italiana Ricerca e Informazione per la Vitiligine; Domande e risposte, su arivonlus.it. URL consultato il 12 giugno 2016 (archiviato dall'url originale il 16 giugno 2016).
AA.VV., Psoriasi e vitiligine, p. 8 (PDF), su asnpv.it. URL consultato il 1º marzo 2016 (archiviato dall'url originale il 5 agosto 2016).
Rateb AAH, Azzam OA, Rashed LA, El-Guindy NM, El-Din MS., The role of nerve growth factor in the pathogenesis of vitligo. (PDF), in JEWDS, vol. 1, 2005, pp. 18-24. URL consultato il 21 aprile 2017 (archiviato dall'url originale il 6 marzo 2009).
Copia archiviata, su arivonlus.it. URL consultato il 12 giugno 2016 (archiviato dall'url originale il 16 giugno 2016).
Lidia Sautebin, I cosmetici sbiancanti: effetti avversi frequenti e potenzialmente gravi, Dipartimento di Farmacologia Sperimentale, Facoltà di Farmacia, Università di Napoli Federico II, su farmacovigilanza.org. URL consultato il 18 agosto 2017 (archiviato dall'url originale il 10 settembre 2014).
DEPIGMENTAZIONE DELLE AREE NON AFFETTE: UNA VALIDA ALTERNATIVA TERAPEUTICA IN FORME STABILI E DIFFUSE DI VITILIGINE., su arivonlus.it. URL consultato il 18 agosto 2017 (archiviato dall'url originale il 18 agosto 2017).
Ingredienti schiarenti a confronto, su nononsensecosmethic.org. URL consultato il 9 ottobre 2018 (archiviato dall'url originale il 9 ottobre 2018).
Melasma Treatment Archiviato il 23 dicembre 2009 in Internet Archive., American Academy of Dermatology.